「bi」の検索結果

Infer integer allele-specific copy number, tumor purity, and ploidy from tumor sequencing by jointly modeling read depth (logR) and B-allele frequency (BAF) with ASCAT, Sequenza, FACETS, PURPLE, and PureCN (tumor-only). Covers the purity-ploidy identifiability problem, the diploid-baseline (dipLogR) anchor, major/minor copy number, loss of heterozygosity, sunrise/contour fit diagnostics, and reconciliation of conflicting fits. Use when tumor analysis needs absolute copy number rather than relative log2, when estimating purity and ploidy, calling LOH or copy-neutral LOH, resolving whole-genome doubling, running tumor-only allele-specific calling, or choosing among ASCAT, Sequenza, FACETS, and PureCN.

日本語の概要は準備中です。原文の説明を表示しています。

Detect antimicrobial resistance genes using AMRFinderPlus, ResFinder, and CARD. Screen isolates and metagenomes for resistance determinants. Use when characterizing resistance profiles in clinical isolates, surveillance samples, or metagenomic data.

日本語の概要は準備中です。原文の説明を表示しています。

Detect and track antimicrobial resistance genes using AMRFinderPlus and ResFinder with epidemiological context. Monitor resistance trends and identify emerging resistance patterns. Use when screening genomes for AMR genes or tracking resistance in surveillance programs.

日本語の概要は準備中です。原文の説明を表示しています。

Analyzes base-editing screens for variant function. Covers library design (Sanson 2020 GRACE, Hanna 2021 BRCA1/2 SNV scanning, Cuella-Martin 2021), CBE vs ABE chemistry choice (BE3/BE4 vs ABE7.10/ABE8.20/ABE8e), editing-window math (positions 4-8 from PAM-distal end, wider for ABE8e), bystander-edit quantification and the variant-call ambiguity it creates, sgRNA-efficiency filtering before hit calling, indel byproduct interpretation, the substitution-vs-indel diagnostic, variant annotation against ClinVar / COSMIC, and the Broad be-validation-pipeline. Use when designing a BE variant screen, choosing CBE vs ABE for a specific edit, interpreting bystander-confounded hits, distinguishing functional signal from indel artifact, integrating CRISPResso2 output with screen scoring, or deciding BE vs PE for SNV installation.

日本語の概要は準備中です。原文の説明を表示しています。

Biology research tools reference. Always available inside agent containers.

日本語の概要は準備中です。原文の説明を表示しています。

Query STRING for protein-protein interactions. Use when user asks about protein interactions, interaction networks, binding partners, or interactome. Triggers on "string", "protein interaction", "interaction network", "binding partners", "interactome", "PPI".

日本語の概要は準備中です。原文の説明を表示しています。

Proteina-Complexa flow-based protein backbone generation with fold-conditioned sampling guidance. Use this skill when: (1) Generating de novo protein backbones with hierarchical fold conditioning, (2) Exploring long-chain backbone generation beyond standard diffusion baselines, (3) Using NVIDIA Proteina-style flow matching workflows for controllable backbone design, (4) Comparing flow-based backbone generation against RFdiffusion or BoltzGen, (5) Prototyping fold-guided backbone campaigns before sequence design. This skill is based on the public NVIDIA Digital Bio Proteina project and uses "Proteina-Complexa" as the BioClaw-facing skill label. For sequence design after backbone generation, use proteinmpnn or solublempnn. For QC thresholds, use protein-design-qc.

日本語の概要は準備中です。原文の説明を表示しています。

Predicts ADMET properties using ADMETlab 3.0 (119 endpoints with uncertainty), ADMET-AI, DeepChem MolNet, and chemprop D-MPNN with explicit handling of OECD QSAR principles, applicability domain assessment, calibration, hERG/CYP/AMES gold-standard endpoints, and PAINS / Lipinski / Ro5 / Veber / BBB druglikeness filters. Use when filtering compounds for drug-likeness, prioritizing leads by predicted safety, or building an in-house ADMET QSAR model.

日本語の概要は準備中です。原文の説明を表示しています。

Structure retrieval, confidence-aware AlphaFold DB usage, coordinate download, PAE and pLDDT interpretation, and structure-guided biological annotation.

日本語の概要は準備中です。原文の説明を表示しています。

Designs adaptive clinical trials including group-sequential (O'Brien-Fleming, Pocock, Lan-DeMets spending), sample-size re-estimation (blinded Friede-Kieser, unblinded Cui-Hung-Wang, Mehta-Pocock promising zone), seamless Phase 2/3 with treatment-arm selection, population enrichment, and response-adaptive randomisation. Covers FDA 2019 Final Adaptive Designs Guidance, FDA 2022 Master Protocols, and ICH E20 Step 2b/3 draft (June 2025, NOT final). Use when planning interim analyses, sample-size re-estimation, or master/platform-trial designs.

日本語の概要は準備中です。原文の説明を表示しています。

ESM2 protein language model for sequence scoring, embeddings, and plausibility checks. Use this skill when: (1) Computing pseudo-log-likelihood (PLL) scores, (2) Getting protein embeddings for clustering, (3) Filtering designs by sequence plausibility, (4) Zero-shot variant effect prediction, (5) Analyzing sequence-function relationships. For structure prediction, use chai1-structure-prediction or boltz-structure-prediction. For QC thresholds, use protein-design-qc.

日本語の概要は準備中です。原文の説明を表示しています。

Structure prediction using Boltz-1/Boltz-2, an open biomolecular structure predictor. Use this skill when: (1) Predicting protein complex structures, (2) Validating designed binders, (3) Need open-source alternative to AF2, (4) Predicting protein-ligand complexes, (5) Using local GPU resources. For QC thresholds, use protein-qc. For AlphaFold2 prediction, use alphafold. For Chai prediction, use chai.

日本語の概要は準備中です。原文の説明を表示しています。

Workflow for amplicon microbiome analysis including denoising, taxonomy assignment, diversity analysis, and differential abundance.

日本語の概要は準備中です。原文の説明を表示しています。

Workflow for predictive modeling, biomarker discovery, survival modeling, and explainability over omics-derived features.

日本語の概要は準備中です。原文の説明を表示しています。

Generate protein backbones using RFdiffusion, a diffusion-based generative model for de novo protein structure generation. Use this skill when: (1) Designing binder scaffolds for a target protein, (2) Generating novel protein backbones from scratch, (3) Scaffolding functional motifs into new proteins, (4) Specifying hotspot residues for interface design, (5) Creating symmetric oligomers. For sequence design after backbone generation, use proteinmpnn. For structure validation, use alphafold or chai. For QC thresholds, use protein-qc.

日本語の概要は準備中です。原文の説明を表示しています。

All-atom protein design using BoltzGen diffusion model. Use this skill when: (1) Need side-chain aware design from the start, (2) Designing around small molecules or ligands, (3) Want all-atom diffusion (not just backbone), (4) Require precise binding geometries, (5) Using YAML-based configuration. For backbone-only generation, use rfdiffusion. For sequence-only design, use proteinmpnn. For structure validation, use boltz.

日本語の概要は準備中です。原文の説明を表示しています。

Goal-oriented binder design campaign planning and health assessment. Use this skill when: (1) Planning a complete binder design campaign, (2) Converting high-level goals into runnable pipelines, (3) Assessing campaign health and pass rates, (4) Diagnosing why designs are failing QC, (5) Estimating time, cost, and expected yields, (6) Selecting between design tools for a specific target. This skill orchestrates the other protein design tools. For individual tool parameters, use the specific tool skills.

日本語の概要は準備中です。原文の説明を表示しています。

Plan, implement, or review observability and instrumentation work in an existing codebase with compatibility, security, and verification controls. Use when the user explicitly requests observability and instrumentation work.

日本語の概要は準備中です。原文の説明を表示しています。

Plan, implement, or review google cloud waf sustainability work in an existing codebase with compatibility, security, and verification controls. Use when the user explicitly requests google cloud waf sustainability work.

日本語の概要は準備中です。原文の説明を表示しています。

Plan, implement, or review google cloud waf reliability work in an existing codebase with compatibility, security, and verification controls. Use when the user explicitly requests google cloud waf reliability work.

日本語の概要は準備中です。原文の説明を表示しています。

Create, implement, or review accessibility review work with format, accessibility, performance, and visual-verification controls. Use when the requested deliverable depends on accessibility review.

日本語の概要は準備中です。原文の説明を表示しています。

Create crafted, accurate visualizations of anatomy, neurobiology, pharmacology, drugs, cells, and molecular biology. Show real biological structures and make their mechanisms visible, using literal anatomy or a clearly identified mechanical metaphor. Build interactive isometric SVG figures with sourced numbers, accessible motion, optional WebGL, a framed card and live readout. Use for biological explainers, educational illustrations, documentation and interactive figures.

日本語の概要は準備中です。原文の説明を表示しています。

Write production-grade Playwright tests in TypeScript: Page Object Model, fixtures, auto-waiting, user-facing locators, parallel execution, CI integration, sharding, and 2025-2026 feature awareness. Includes an explicit "do not" list for AI agents. Use when: "Playwright," "write E2E test," "page object," "new Playwright suite," "Playwright config." Not for: fixing one flaky test at runtime — use test-reliability. Not for: bulk regenerating selectors after a UI refactor — use selector-drift-recovery. Not for: visual baseline creation/management — use visual-testing. Not for: deep WCAG/axe audits — use accessibility-testing. Related: visual-testing, ci-cd-integration, api-testing, test-reliability, selector-drift-recovery, accessibility-testing.

日本語の概要は準備中です。原文の説明を表示しています。

Diagnoses email deliverability problems for transactional and marketing emails. Checks SPF/DKIM/DMARC alignment, sending IP reputation, email content spam triggers, and bounce patterns. Use when emails land in spam, go missing, or bounce unexpectedly. Trigger words: email spam, deliverability, emails not arriving, bounce rate, spam folder, email reputation, SPF fail, DKIM fail, DMARC, transactional email, SendGrid, Postmark, SES.

日本語の概要は準備中です。原文の説明を表示しています。